Navigation Links
Medical Imaging Markets: Contrast Agents
Date:10/26/2011

NEW YORK, Oct. 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Imaging Markets: Contrast Agents

http://www.reportlinker.com/p0158569/Medical-Imaging-Markets-Contrast-Agents.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.

Since our last round-up of the contrast media market, the economic environment in the world has changed. Although the recession may have caused hospitals, physician offices and other institutions to delay or cancel the purchase of imaging equipment, it has not had a significant negative impact on the use of contrast agents with the equipment already on hand. Specifically, annual growth for medical contrast media during the next five years appears to be strong, despite the recession slowing capital equipment purchases. Imaging exams are still needed for many diagnoses, and contrast enhancement facilitates diagnosis in many cases. Kalorama expects growth ranges to remain high.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of the author's medical imaging market reports.

Coverage includes:

  • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2012. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

  • Market share of the major contrast agent supplers

  • Procedure volumes by modality and region

  • Estimates of the portion of procedures in each modality using contrast enhancement

  • Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging's role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer's, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

  • Acusphere Inc.

  • Alseres Pharmaceuticals Inc.

  • Amag Pharmaceuticals Inc.

  • Aposense Ltd.

  • Avid Radiopharmaceuticals Inc.

  • Bayer Schering Pharma

  • Bracco SpA

  • 5.10 Cell Point

  • Covidien Ltd.

  • Daiichi Pharmaceutical Co. Ltd.

  • Dendritic NanoTechnologies Inc.

  • Draximage

  • Endocyte Inc.

  • Eusa Pharma

  • GE Healthcare

  • Guerbet Group

  • Hovione FarmaCiencia SA

  • Imcor Pharmaceutical Co.

  • Immunomedics Inc.

  • Insight Agents GmbH

  • King Pharmaceuticals Inc.

  • Luna nanoWorks

  • Macrocyclics

  • MDS Nordion

  • NanoScan Imaging

  • Palatin Technologies Inc.

  • Pharmacyclics

  • Point Biomedical Corp.

  • Starpharma Holdings Ltd.

  • VisEn Medical Inc.

1.0 EXECUTIVE SUMMARY

1.1 The Contrast Revolution

1.2 X-Ray and CT

1.3 Ultrasound

1.4 MRI

1.5 Radiopharmaceuticals

1.6 World Market Summary

1.6.1 Market Drivers and Trends

1.6.2 Market Challenges

1.6.2.1 Generics

1.6.3 World Market Growth Analysis

1.7 Methodology

2.0 INTRODUCTION

2.1 Harnessing Science to Optimize Outcomes

2.2 History and Evolution

2.3 Key Markets

2.3.1 X-Ray and CT

2.3.2 Ultrasound

2.3.2.1 Microbubbles

2.3.3 MRI

2.3.3.1 Novel Agents

2.3.4 Nuclear Medicine

2.3.4.1 Diagnostics

2.3.4.2 Sourcing Issues

2.3.4.3 PET

2.3.4.3.1 New Applications

2.3.4.4 SPECT

2.3.4.5 Gamma Cameras

2.4 Ionic and Non-Ionic Contrast

2.5 Reimbursement and Other Concerns

2.5.1 Volume Determination

2.5.2 Safety

2.5.3 Combination Technology

3.0 PROMISING DEVELOPMENTS

3.1 Detecting Prostate Cancer

3.2 Assessing Heart Risk

3.3 Breast Chemo Outcome

3.4 Software Enhancement

3.5 Four in One

3.6 Photoacoustic Tomography

3.7 Carbon Do

3.8 Nanomagnets

3.9 Kidney Damage

3.10 Angiograph

3.11 Iodinated Contras

3.12 Children

3.13 Dynamic Contrast-Enhanced MRI

3.14 Preclinica

3.15 Nanocolloid

4.0 MARKET

4.1 Market Drivers

4.1.1 Targeted Imaging

4.1.2 Increasing Specificity

4.1.3 Aging Population

4.2 Utilization

4.2.1 Procedures

4.3 Outlook for Contrast Media

4.3.1 Market Forecast

4.4 Outlook for Molecular Imaging Agents

4.4.1 Market Forecast

5.0 CORPORATE PROFILES

Acusphere Inc.

Alseres Pharmaceuticals Inc.

Amag Pharmaceuticals Inc.

Aposense Ltd.

Avid Radiopharmaceuticals Inc.

Bayer Schering Pharma

Bracco SpA

5.10 Cell>Point

Covidien Ltd.

Daiichi Pharmaceutical Co. Ltd.

Dendritic NanoTechnologies Inc.

Draximage

Endocyte Inc.

Eusa Pharma

GE Healthcare

Guerbet Group

Hovione FarmaCiencia SA

Imcor Pharmaceutical Co.

Immunomedics Inc.

Insight Agents GmbH

King Pharmaceuticals Inc.

Luna nanoWorks

Macrocyclics

MDS Nordion

NanoScan Imaging

Palatin Technologies Inc.

Pharmacyclics

Point Biomedical Corp.

Starpharma Holdings Ltd.

VisEn Medical Inc.

LIST OF EXHIBITS

1.0 EXECUTIVE SUMMARY

Exhibit 1: World Market for X-Ray Medical Contrast Media , 2008-2012

Exhibit 2: World Market for CT Medical Contrast Media 2008-2012

Exhibit 3: World Market for Ultrasound Medical Contrast Media , 2008-2012

Exhibit 4: World Market for MRI Medical Contrast Media 2008-2012

Exhibit 5: World Market for PET Radiopharmaceuticals, 2008-2012

Exhibit 6: World Market for SPECT Radiopharmaceuticals , 2008-2012

2.0 INTRODUCTION

Exhibit 7: Key Medical Contrast Agents by Type

Exhibit 8: Advantages of Non-Ionic Contrast Media

4.0 MARKETS

Exhibit 10: World Market for Medical Contrast Media and Radiopharmaceuticals, 2007-2012

Exhibit 11: World Market Share for Medical Contrast Media and Radiopharmaceuticals, 2009

Exhibit 12: World Market Share for Medical Contrast Media and Radiopharmaceuticals, 2012

Exhibit 13: Key Players' Percentage Share - Worldwide Medical Contrast Media Market

Exhibit 14: World Market Geographic Segmentation for Medical X-Ray Procedures, 2008

Exhibit 15: World Market Geographic Segmentation for Medical X-Ray Procedures, 2008

Exhibit 16: Worldwide Medical MRI Procedures, 2008

Exhibit 17: World Market Geographic Segmentation for Medical MRI Procedures, 2008

Exhibit 18: Worldwide Medical CT Procedures, 2008

Exhibit 19: World Market Geographic Segmentation for Medical CT Procedures, 2008

Exhibit 20: Worldwide Medical Ultrasound Procedures, 2008

Exhibit 21: World Market Geographic Segmentation for Medical Ultrasound Procedures, 2008

Exhibit 22: Worldwide Medical PET Procedures, 2008

Exhibit 23: World Market Geographic Segmentation for Medical PET Procedures

Exhibit 24: Status of Selected Medical Imaging Agents

Exhibit 25: World Market for X-Ray Contrast Media, 2007-2012

Exhibit 26: World Market for Medical X-Ray Contrast Media by Geographic Segment 2007-2012

Exhibit 27: World Market for Medical X-Ray Contrast Media by Geographic Segment, 2008

Exhibit 28: World Market for Medical CT Contrast Media, 2007-2012

Exhibit 29: World Market for Medical CT Contrast Media by Geographic Segment, 2007-2012

Exhibit 30: World Market for Medical CT Contrast Media by Geographic Segment, 2008

Exhibit 31: World Market for Medical Ultrasound Contrast Media, 2007-2012

Exhibit 32: World Market for Medical Ultrasound Contrast Media by Geographic Segment, 2007-2012

Exhibit 33: World Market for Medical Ultrasound Contrast Media by Geographic Segment, 2008

Exhibit 34: World Market for Medical MRI Contrast Media, 2007-2012

Exhibit 35: World Market for Medical MRI Contrast Media by Geographic Segment, 2007-2012

Exhibit 36: World Market for Medical MRI Contrast Media by Geographic Segment, 2008

Exhibit 37: Selected Molecular Imaging Products

Exhibit 38: World Market for Medical PET Radiopharmaceuticals, 2007-2012

Exhibit 39: World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2007-2012

Exhibit 40: World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2008

Exhibit 41: World Market for Medical SPECT Radiopharmaceuticals, 2007-2012

Exhibit 42: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2007-2012

Exhibit 43: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2008

To order this report:

Medical Imaging Industry: Medical Imaging Markets: Contrast Agents

More  Market Research Report

Check our  Real Time Industry Data

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Detroit Medical Center Shares Smart Room Case Study at CHIME 2011 Fall CIO Forum
2. UBM Canons 2012 Medical Design Excellence Awards Calls for Entries
3. Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland
4. Mindray Medical to Exhibit New Products at 66th China International Medical Equipment Fair
5. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
6. China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Companys Convertible Notes in August 2008
7. Solta Medical Reports FDA Clearance Received for Second Generation LipoSonix® System
8. Phreesia Continues to Enhance its Market-Leading Eligibility and Benefits Verification Process for Medical Practices
9. Emerging Medical Devices Technology Trends - 2011
10. Medical Alarm and Harrington Multi Media Schedule Production for MediPendant™ National Television Launch
11. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment of ... doses of biotin in progressive multiple sclerosis: extension phase results ... Ayman Tourbah , Principal Investigator of the Phase 3 study, ... (EAN) in Copenhagen, Denmark . The oral ... Sunday, 29 May 2016 from 14:45 to 16:15 CEST in ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... Each year Standard Process Inc. ... is this year’s Life University winner of a $2,500 scholarship from ... Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life University ...
(Date:5/26/2016)... ... ... last week’s media reports hinting at a June rate hike after the Federal Reserve’s ... interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at Georgia ... (FOMC) dot charts are of interest to the press for their noise potential,” Dhawan ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., ... with a 2016 When Work Works Award for its use of effective workplace strategies ... When Work Works project administered by the Families and Work Institute (FWI) and the ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Chicago, Illinois (PRWEB) , ... May 26, 2016 , ... ... relationship with women’s basketball as a partner for the Tamika Catchings Legacy Tour ... , As the industry leader in hardwood basketball surfaces in all forms and levels ...
Breaking Medicine News(10 mins):